A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer

Background Gastric cancer (GC) is characterised by a heterogeneous tumour microenvironment (TME) that is closely associated with the response to treatment, especially immunotherapies. However, most previous GC molecular subtyping systems need complex gene signatures and examination methods, restricting their clinical applications. Thus, we developed a new TME-based molecular subtype using only two genes. Methods Nine independent GC cohorts at the tissue- or single-cell level with more than 2000 patients were used in this study, including data we examined by single-cell sequencing, quantitative RT-PCR and immunochemistry/immunofluorescence staining. Nine different methods, five existing molecular subtypes and a series of signatures were used to evaluate the TME and molecular characteristics of GC. Results We established a CTSL/ZBTB7B subtyping system and uncovered the novel CTSL(High)ZBTB7B(Low) high-risk subgroup, but characterised by relative higher immune cell infiltration and lower tumour purity. This subgroup demonstrate higher levels of immune checkpoints and more enrichment of cancer-related pathways compared with other cases. Conclusions We identified a high-risk subpopulation with unique TME features based on expressions of CTSL and ZBTB7B, suggesting a counterbalancing phenotype between immunostimulatory and immunosuppressive mechanisms. This subtyping system could be used to select treatment and management strategies for GC.

Automated summary

In this study, a new TME-based molecular subtype was developed using only two genes (CTSL and ZBTB7B) to identify a high-risk subgroup with unique tumor microenvironment features. This finding has potential implications for selecting treatment and management strategies for gastric cancer.